Davis James H

Avg. Two Year Performance

No purchase track record

22% Avg. Sale Return

10% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	(3%)	5%	11%	14%	22%
Sale Success Rate	7 of 11	8 of 11	9 of 11	8 of 11	6 of 11

Human Genome Sciences Inc.

Drugs » Diagnostic Substances

Exec. VP, Gen Counsel & Sec.:

Holdings: 0 shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--